Predict your next investment

Clover Biopharmaceuticals company logo
HEALTHCARE | Biotechnology
cloverbiopharma.com

See what CB Insights has to offer

Executives

5

Board of Directors

2

Clover Biopharmaceuticals Board of Directors

2 Board of directors

Clover Biopharmaceuticals has 2 board of directors, including Joshua Liang.

Name

Firm

Work History

Other Seats

Joshua Liang

Executive, Healthcare Investment Banking, Centerview Partners; Leader, Healthcare Sector, Global Platinum Securities

Tim Xiao

Tim Xiao, CFA, FRM, is a Principal at Delos Capital since its inception in 2014 and has over 12 years’ experience in investment banking and life sciences investment. Tim started his career as an investment banker at China International Capital, and later joined Goldman Sachs where he completed a series of industry-defining transactions with total deal value over US $4 billion. Tim serves as a Board member for Liposeuticals, Curatia Medical, Luqa Pharmaceuticals, Thermalin Inc., and as a Board Observer for Allecra Therapeutics, Intrinsic Therapeutics, and Atia Vision. Tim is a CFA® charterholder.

Allecra Therapeutics, Intrinsic Therapeutics, Luqa Pharmaceuticals, OncoMyx Therapeutics, and Thermalin

Name

Joshua Liang

Tim Xiao

Firm

Work History

Executive, Healthcare Investment Banking, Centerview Partners; Leader, Healthcare Sector, Global Platinum Securities

Tim Xiao, CFA, FRM, is a Principal at Delos Capital since its inception in 2014 and has over 12 years’ experience in investment banking and life sciences investment. Tim started his career as an investment banker at China International Capital, and later joined Goldman Sachs where he completed a series of industry-defining transactions with total deal value over US $4 billion. Tim serves as a Board member for Liposeuticals, Curatia Medical, Luqa Pharmaceuticals, Thermalin Inc., and as a Board Observer for Allecra Therapeutics, Intrinsic Therapeutics, and Atia Vision. Tim is a CFA® charterholder.

Other Seats

Allecra Therapeutics, Intrinsic Therapeutics, Luqa Pharmaceuticals, OncoMyx Therapeutics, and Thermalin

Clover Biopharmaceuticals Management Team

5 Team Members

Clover Biopharmaceuticals has 5 executives. Clover Biopharmaceuticals's founder is Peng Liang. Clover Biopharmaceuticals's current Chief Executive Officer is Joshua Liang.

Name

Work History

Title

Status

Peng Liang

Founder

Current

Joshua Liang

Chief Executive Officer

Current

Htay Htay Han

Chief Medical Officer

Current

Min Dong

Executive Vice President

Current

Xiaobing Li PhD MBA PMP

Executive Vice President

Current

Name

Peng Liang

Joshua Liang

Htay Htay Han

Min Dong

Xiaobing Li PhD MBA PMP

Work History

Title

Founder

Chief Executive Officer

Chief Medical Officer

Executive Vice President

Executive Vice President

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.